<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34978044</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>07</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1559-1182</ISSN><JournalIssue CitedMedium="Internet"><Volume>59</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Molecular neurobiology</Title><ISOAbbreviation>Mol Neurobiol</ISOAbbreviation></Journal><ArticleTitle>Reduced mtDNA Copy Number in the Prefrontal Cortex of C9ORF72 Patients.</ArticleTitle><Pagination><StartPage>1230</StartPage><EndPage>1237</EndPage><MedlinePgn>1230-1237</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12035-021-02673-7</ELocationID><Abstract><AbstractText>Hexanucleotide repeat expansion in C9ORF72 gene is the most common genetic cause of amyotrophic lateral sclerosis and frontotemporal dementia (C9ALS/FTD). Loss of C9ORF72 protein function and a toxic gain-of-function directly by the RNA or RAN translation have been proposed as triggering pathological mechanisms, along with the accumulation of TDP-43 protein. In addition, mitochondrial defects have been described to be a major driver of disease initiation. Mitochondrial DNA copy number has been proposed as a useful biomarker of mitochondrial dysfunction. The aim of our study was to determine the presence of mtDNA copy number alterations in C9ALS/FTD patients. Therefore, we assessed mtDNA copy number in postmortem prefrontal cortex from 18 C9ORF72 brain donors and 9 controls using digital droplet PCR. A statistically significant decrease of 50% was obtained when comparing C9ORF72 samples and controls. This decrease was independent of age and sex. The reduction of mtDNA copy number was found to be higher in patients' samples presenting abundant TDP-43 protein inclusions. A growing number of studies demonstrated the influence of mtDNA copy number reduction on neurodegeneration. Our results provide new insights into the role of mitochondrial dysfunction in the pathogenesis of C9ALS/FTD.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alvarez-Mora</LastName><ForeName>Maria Isabel</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Biochemistry and Molecular Genetics Department, Hospital Clinic of Barcelona, C/Villarroel, 170, 08036, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER of Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Podlesniy</LastName><ForeName>Petar</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>CIBER of Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riazuelo</LastName><ForeName>Teresa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Biochemistry and Molecular Genetics Department, Hospital Clinic of Barcelona, C/Villarroel, 170, 08036, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molina-Porcel</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Neurological Tissue Bank of the Biobank-Hospital Clinic-IDIBAPS, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Cl&#xed;nic, Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gelpi</LastName><ForeName>Ellen</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez-Revenga</LastName><ForeName>Laia</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-6332-3929</Identifier><AffiliationInfo><Affiliation>Biochemistry and Molecular Genetics Department, Hospital Clinic of Barcelona, C/Villarroel, 170, 08036, Barcelona, Spain. lbodi@clinic.cat.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER of Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain. lbodi@clinic.cat.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. lbodi@clinic.cat.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PI17/01067</GrantID><Agency>instituto de salud carlos iii</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Neurobiol</MedlineTA><NlmUniqueID>8900963</NlmUniqueID><ISSNLinking>0893-7648</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568651">C9orf72 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004272">DNA, Mitochondrial</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056915" MajorTopicYN="N">DNA Copy Number Variations</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042622" MajorTopicYN="N">DNA Repeat Expansion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004272" MajorTopicYN="N">DNA, Mitochondrial</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017397" MajorTopicYN="N">Prefrontal Cortex</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">C9ALS/FTD</Keyword><Keyword MajorTopicYN="N">C9ORF72</Keyword><Keyword MajorTopicYN="N">Neurodegeneration</Keyword><Keyword MajorTopicYN="N">ddPCR</Keyword><Keyword MajorTopicYN="N">mtDNA copy number</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>3</Day><Hour>6</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34978044</ArticleId><ArticleId IdType="doi">10.1007/s12035-021-02673-7</ArticleId><ArticleId IdType="pii">10.1007/s12035-021-02673-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF et al (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72:245&#x2013;256</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A et al (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72:257&#x2013;268</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Gijselinck I, Van Langenhove T, van der Zee J et al (2012) A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study. Lancet Neurol 11:54&#x2013;65</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(11)70261-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YB, Chen HJ, Peres JN et al (2013) Hexanucleotide repeats in ALS/FTD form length-dependent RNA foci, sequester RNA binding proteins, and are neurotoxic. Cell Rep 5:1178&#x2013;1186</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.10.049</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez CM, Todd PK (2019) New pathologic mechanisms in nucleotide repeat expansion disorders. Neurobiol Dis 130:104515</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104515</ArticleId></ArticleIdList></Reference><Reference><Citation>Green KM, Linsalata AE, Todd PK (2016) RAN translation-what makes it run? Brain Res 1647:30&#x2013;42</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.04.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Saberi, S. Stauffer JE, Jiang J, et al. (2018) Sense-encoded poly-GR dipeptide repeat proteins correlate to neurodegeneration and uniquely co-localize with TDP-43 in dendrites of repeat-expanded C9orf72 amyotrophic lateral sclerosis. Acta Neuropathol 135: 459&#x2013;474.</Citation></Reference><Reference><Citation>Sakae, N. Bieniek KF, Zhang YJ, et al. (2018) Poly-GR dipeptide repeat polymers correlate with neurodegeneration and clinicopathological subtypes in C9ORF72-related brain disease. Acta Neuropathol Commun 6: 63.</Citation></Reference><Reference><Citation>Mackenzie IR, Frick P, Neumann M (2014) The neuropathology associated with repeat expansions in the C9ORF72 gene. Acta Neuropathol 127:347&#x2013;357</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1232-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Babi&#x107; Leko M, &#x17d;upunski V, Kirincich J et al (2019) Molecular mechanisms of neurodegeneration related to C9orf72 hexanucleotide repeat expansion. Behav Neurol 2019:2909168</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/2909168</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SR, Han J (2017) Mitochondrial nucleoid: shield and switch of the mitochondrial genome. Oxid Med Cell Longev 2017:8060949</Citation><ArticleIdList><ArticleId IdType="pubmed">28680532</ArticleId><ArticleId IdType="pmc">5478868</ArticleId></ArticleIdList></Reference><Reference><Citation>Podlesniy P, Figueiro-Silva J, Llado A et al (2013) Low cerebrospinal fluid concentration of mitochondrial DNA in preclinical Alzheimer disease. Ann Neurol 74:655&#x2013;668</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23955</ArticleId></ArticleIdList></Reference><Reference><Citation>Podlesniy P, Vilas D, Taylor P et al (2016) Mitochondrial DNA in CSF distinguishes LRRK2 from idiopathic Parkinson&#x2019;s disease. Neurobiol Dis 94:10&#x2013;17</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2016.05.019</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi SY, Lopez-Gonzalez R, Krishnan G et al (2019) C9ORF72-ALS/FTD-associated poly(GR) binds Atp5a1 and compromises mitochondrial function in vivo. Nat Neurosci 22:851&#x2013;862</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0397-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gonzalez R, Lu Y, Gendron TF et al (2016) Poly(GR) in C9ORF72-related ALS/FTD compromises mitochondrial function and increases oxidative stress and DNA damage in iPSC-derived motor neurons. Neuron 92:383&#x2013;391</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.09.015</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez-Mora MI, Podlesniy P, Gelpi E et al (2019) Fragile X-associated tremor/ataxia syndrome: regional decrease of mitochondrial DNA copy number relates to clinical manifestations. Genes Brain Behav 18:e12565</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/gbb.12565</ArticleId></ArticleIdList></Reference><Reference><Citation>Cowan K, Anichtchik O, Luo S (2019) Mitochondrial integrity in neurodegeneration. CNS Neurosci Ther 25:825&#x2013;836</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.13105</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Osenbroch P, Skinnes R et al (2010) Mitochondrial DNA integrity is essential for mitochondrial maturation during differentiation of neural stem cells. Stem Cells 28:2195&#x2013;2204</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.542</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk R, Nooteboom M, Osiewacz HD (2014) Control of mitochondrial integrity in ageing and disease. Philos Trans R Soc Lond B Biol Sci 369:20130439</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rstb.2013.0439</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei W, Keogh MJ, Wilson I et al (2017) Mitochondrial DNA point mutations and relative copy number in 1363 disease and control human brains. Acta Neuropathol Commun 5:13</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0404-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen MH, Budtz-J&#xf8;rgensen E, S&#xf8;rensen SA et al (2014) Reduction in mitochondrial DNA copy number in peripheral leukocytes after onset of Huntington&#x2019;s disease. Mitochondrion 17:14</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2014.05.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Rice AC, Keeney PM, Algarzae NK et al (2014) Mitochondrial DNA copy numbers in pyramidal neurons are decreased and mitochondrial biogenesis transcriptome signaling is disrupted in Alzheimer&#x2019;s disease hippocampi. J Alzheimers Dis 40:319&#x2013;330</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-131715</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalil B, Li&#xe9;vens JC (2017) Mitochondrial quality control in amyotrophic lateral sclerosis: towards a common pathway? Neural Regen Res 12:1052&#x2013;1061</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.211179</ArticleId></ArticleIdList></Reference><Reference><Citation>Dafinca R, Scaber J, Ababneh N et al (2016) C9orf72 hexanucleotide expansions are associated with altered endoplasmic reticulum calcium homeostasis and stress granule formation in induced pluripotent stem cell-derived neurons from patients with amyotrophic lateral sclerosis and frontotemporal dementia. Stem Cells 34:2063&#x2013;2078</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.2388</ArticleId></ArticleIdList></Reference><Reference><Citation>Paillusson S, Stoica R, Gomez-Suaga P et al (2016) There&#x2019;s something wrong with my MAM; the ER-mitochondria axis and neurodegenerative diseases. Trends Neurosci 39:146&#x2013;157</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2016.01.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson YS, Barker H, Robinson AC et al (2014) Brain distribution of dipeptide repeat proteins in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72. Acta Neuropathol Commun 2:70</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2051-5960-2-70</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Arzberger T, Kremmer E et al (2013) Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations. Acta Neuropathol 126:859&#x2013;879</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1181-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Zu T, Liu Y, Banez-Coronel M et al (2013) RAN proteins and RNA foci from antisense transcriptsinC9ORF72ALSandfrontotemporaldementia. Proc Natl Acad Sci 110:E4968&#x2013;E4977</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1315438110</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YB, Baskaran P, Gomez-Deza J et al (2017) C9orf72 poly GA RAN-translated protein plays a key role in amyotrophic lateral sclerosis via aggregation and toxicity. Hum Mol Genet 26:4765&#x2013;4777</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx350</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew J, Gendron TF, Prudencio M et al (2015) Neurodegeneration. C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits. Science 348:1151&#x2013;1154</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa9344</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron TF, Petrucelli L (2018) Disease mechanisms of C9ORF72 repeat expansions. Cold Spring Harb Perspect Med 8:a024224</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a024224</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose J, Brian C, Woods J et al (2017) Mitochondrial dysfunction in glial cells: implications for neuronal homeostasis and survival. Toxicology 391:109&#x2013;115</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tox.2017.06.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos-Campoy O, Avila-Polo R, Grau-Rivera O et al (2018) Systematic screening of ubiquitin/p62 aggregates in cerebellar cortex expands the neuropathological phenotype of the C9orf72 expansion mutation. J Neuropathol Exp Neurol 77:703&#x2013;709</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nly047</ArticleId></ArticleIdList></Reference><Reference><Citation>Briston T, Hicks AR (2018) Mitochondrial dysfunction and neurodegenerative proteinopathies: mechanisms and prospects for therapeutic intervention. Biochem Soc Trans 46:829&#x2013;842</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST20180025</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Frick P, Gr&#xe4;sser FA et al (2015) Quantitative analysis and clinico-pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers. Acta Neuropathol 130:845&#x2013;861</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1476-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Schludi MH, May S, Grasser FA et al (2015) Distribution of dipeptide repeat proteins in cellular models and C9orf72 mutation cases suggests link to transcriptional silencing. Acta Neuropathol 130:537&#x2013;555</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1450-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Montine T, Phelps CH, Beach TG et al (2012) (2012) National Institute on Aging-Alzheimer&#x2019;s Association guidelines for the neuropathologic assessment of Alzheimer&#x2019;s disease: a practical approach. Acta Neuropathol 123:1&#x2013;11</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0910-3</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>